Suchergebnisse - %22Adalimumab%22

PubPharm (5)

1

Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease

enthalten in: The American journal of gastroenterology | 2009

von Marehbian, J. | Arrighi, H. | Hass, S. | +2

CommentIn: Inflamm Bowel Dis. 2010 Aug;16(8):1443-4. - PMID 19834975

2

Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis : effect of TNFalpha antagonist therapy

enthalten in: Joint bone spine | 2008

von Wendling, D. | Cedoz, J. | Racadot, E.

3

Caspase activation and apoptosis induction by adalimumab : demonstration in vitro and in vivo in a chimeric mouse model

enthalten in: Inflammatory bowel diseases | 2006

von Shen, C. | Van Assche, G. | Rutgeerts, P. | +1

4

New drugs 04, part 1

enthalten in: Nursing | 2004

von Hussar, D.

5

How future tumor necrosis factor antagonists and other compounds will meet the remaining challenges in Crohn's disease

enthalten in: Reviews in gastroenterological disorders | 2004

von Sandborn, W.

1
[1]